← Back to Search

Automated SMS program to support post-discharge transitions of care for Transition Care (MORE-PC Trial)

N/A
Waitlist Available
Led By Anna Morgan, MD, MSHP
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The study subjects will be medium to high risk (UPHS risk score 4 and above; an internally developed and validated score assessing a patient's risk for readmission) adult (age ≥ 18) patients of the Penn Primary Care Practices who are discharged home from acute inpatient care in the broad Philadelphia region as identified in HealthShare Exchange (HSX) reports
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7, 30, and 60 days post-discharge
Awards & highlights

MORE-PC Trial Summary

This trial will study how well a 30-day post-discharge intervention using an automated SMS platform works to monitor patients and communicate with their primary care practice.

MORE-PC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MORE-PC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7, 30, and 60 days post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7, 30, and 60 days post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Number of patient-practice interactions
Post-discharge ED visit
Post-discharge acute care utilization
+4 more

MORE-PC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 30-day automated hovering + usual careExperimental Treatment1 Intervention
The intervention arm will get the usual post-discharge call from their practice, typically within 2 business days of discharge. In addition, they will be enrolled in the 30-day automated texting program, wherein they will receive check-in messages on a tapering schedule; they will be free to opt out at any time. They can also message into the platform at any time. Any needs identified through the platform will be escalated to their primary care practice, and they will receive a follow-up phone call from practice staff to address their needs.
Group II: Usual careActive Control1 Intervention
The control arm will continue to receive the usual post-discharge call from their practice, typically within 2 business days of discharge.

Find a Location

Who is running the clinical trial?

UnitedHealth GroupIndustry Sponsor
12 Previous Clinical Trials
5,811 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,003 Previous Clinical Trials
42,876,999 Total Patients Enrolled
3 Trials studying Transition Care
8,473 Patients Enrolled for Transition Care
Anna Morgan, MD, MSHPPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care
2022. "MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05245773.
~1667 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top